Entacapone - a novel COMT-inhibitor in the treatment of Parkinson's disease : programme and abstracts

about
contributor
inLanguage
  • en
isPartOf
name
  • Entacapone - a novel COMT-inhibitor in the treatment of Parkinson's disease : programme and abstracts
P60049

Instances

Entacapone - a novel COMT-inhibitor in the treatment of Parkinson's disease : programme and abstracts

datePublished
  • 1997
description
  • kuvitettu
  • Orion Pharma Symposium to the XIIth International Symposium on Parkinson's Disease, Monday, March 24, 1997, 17.00-19.00, London, the Queen Elizabeth II Conference Centre, Whittle Room.
identifier
  • propertyID: FI-FENNI value: 584489
  • propertyID: FI-MELINDA value: 000877700
  • propertyID: skl value: f980965
isPartOf
name
  • Entacapone - a novel COMT-inhibitor in the treatment of Parkinson's disease : programme and abstracts
numberOfPages
  • 14 s.
P60048
P60050
publication
  • location: Espoo organizer: Orion Corporation, Orion Pharma International
publisher
  • Orion Corporation, Orion Pharma International

Download this resource as RDF: